Experts who advise the U.S. Food and Drug Administration (FDA) on April 6 came out in opposition to a strategy of repeated COVID-19 vaccine boosters within a short period of time, during a meeting where FDA officials said they plan on deciding on the future vaccination strategy by June. “I do not believe that booster every eight weeks or even four months is a long-term strategy for prevention,” Dr. Amanda Cohn, a Centers for Disease Control and Prevention official, said during a virtual meeting of the FDA’s Vaccines and Related Biological Products Advisory Committee. “We don’t feel comfortable with multiple boosters every eight weeks,” Dr. Arnold Monto, the committee’s acting chair, said later. “Would love to see annual vaccination, similar to influenza.” The FDA in March authorized second boosters of the Pfizer and Moderna COVID-19 vaccines four months after the initial booster for all Americans 50 and older, and some as …